Clinical Trial Update: Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether an intensified initial dosing regimen of mycophenolate sodium provides therapeutic benefit over a standard regimen in renal tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Novartis | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-01-11